Capitol Hill U.S. government shuts downImpact on NCI uncertain as administration threatens more RIFs October 03, 2025Vol.51 No.36By Claire Marie Porter
Guest Editorial Sexual and gender minoritized cancer patients deserve better October 03, 2025Vol.51 No.36By Don S. Dizon and Binay Shah
FreeGuest Editorial Seeding NCORPs with academically-focused oncologists can advance the national research agenda October 03, 2025Vol.51 No.36By Amarinthia (Amy) Curtis
Sponsored The evolution of cellular immunotherapy: From transplant to CAR T cells October 03, 2025Vol.51 No.36By Stephen J. Forman
News AnalysisRegulatory News Trump’s FDA invents an unusual regulatory pathway to approve leucovorin for autismExperts call the move “extremely premature” September 26, 2025Vol.51 No.35By Claire Marie Porter and Paul Goldberg
Guest Editorial Population-based cancer surveillance is a national treasure at risk September 26, 2025Vol.51 No.35By Eric B. Durbin, Karen L. Knight, Betsy Kohler and Sarah Nash
Sponsored Ci4CC’s 24th Symposium & Workshop set to focus on precision oncology powered by data intelligence September 26, 2025Vol.51 No.35By Stephen D. Nimer
Trials & Tribulations Earlier diagnosis, better outcomes: Telemedicine has found a home in oncology September 26, 2025Vol.51 No.35By Hardeep Phull
Guest Editorial Championing nurse wellbeing as a strategic priority September 26, 2025Vol.51 No.35By Kim Slusser
FreeIn the Archives Michael Link reflects on his ASCO presidential term, concerns for the future of oncology—and hope for children with cancer September 26, 2025Vol.51 No.35
